Skip to content
value.today

Lorus Therapeutics Inc.

Total raised
$28 M
1 round on record
Latest round
$28 M
Apr 2014
First round on record
Apr 2014
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Lorus Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2014$28 MNo. 1$10 to $50 million

Lorus Therapeutics Inc.: Raise no. 1, Apr 2014

Investors in this round

3 investors had bought by the notice of Apr 24, 2014: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $29 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,977,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Avanish A Vellanki · Executive Officer
  • Gregory A Chow · Executive Officer
  • William G Rice · Executive Officer, Director
  • Brad A Thompson · Director
  • Brian A Underdown · Director
  • Denis A Burger · Director
  • Jim A Wright · Director
  • Mark A Vincent · Director
  • Warren A Whitehead · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cormark Securities Inc. (CRD 101000) · broker-dealer Cormark Securities Inc. (CRD 101000) · Toronto, Ontario, CanadaSold in no state named, and outside the US
  • RBC Dominion Securities Inc. · broker-dealer RBC Dominion Securities Inc. · Toronto, Ontario, CanadaSold in no state named, and outside the US
  • Roth Capital Partners, LLC (CRD 15407) · broker-dealer Roth Capital Partners, LLC (CRD 15407) · Newport Beach, CaliforniaSold in CA

Signed by Gregory Chow, Cfo. Source: SEC Form D, newest notice filed Apr 24, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Lorus Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2014).

    SEC Form D · Apr 2014

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2014

That is all the official record says: Lorus Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Lorus Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Lorus Therapeutics Inc.
NameRoleNamed in
Avanish A VellankiExecutive officerApr 2014
Gregory A ChowExecutive officerApr 2014
William G RiceExecutive officerApr 2014
Brad A ThompsonDirectorApr 2014
Brian A UnderdownDirectorApr 2014
Denis A BurgerDirectorApr 2014
Jim A WrightDirectorApr 2014
Mark A VincentDirectorApr 2014
Warren A WhiteheadDirectorApr 2014
William G RiceDirectorApr 2014